Though there are no national survey records, it is estimated that deaths due to cancer are approximated at 120 per 100,000. And the assumption is that there are 35000 to 40000 cancer patients in the country at any given space of time.
B.P. Koirala Memorial Cancer Hospital (BPKMCH) was the first national cancer center of its kind for the fight against cancer in Nepal. The felt need of the hour was a competent establishment that would be able to fulfill the need of the people of Nepal. In a country rife with poverty, illiteracy the harsh geographical terrain and an almost negligible access to basic health facilities, this institution is envisioned to bridge that gap.
The innovations and findings made in the medical science across the world have also improved the health condition of Nepalese people. Control over some communicable diseases, improved obstetric care and better coverage in immunization has increased life expectancy. The improved communication facilities including greater opportunity for education and rapidly growing urbanization are contributory factors to changes in life style and human behavior. Yet the general trend can not be stated to be satisfactorily. The magnitude of the problem and the impact of the increased, indiscriminate and irrational use of chemicals in the farms, adulteration along with improper storage of food materials are yet to be assessed.
The Government of Nepal has declared health care as the fundamental right of every citizen. Hospitals face the major challenge of moving ahead with this sentiment and of making available their services to each and every patient. Since the treatment of cancer is very expensive, much attention must be given to prevention and early detection of the disease.
Treatment Approach
The common approach to various cancers is “risk adapted therapy” regarding the long-term life expectancy. Patients with solid tumors receive multidisciplinary therapy, including surgical removal of the tumor, radiation therapy and chemotherapy as indicated. Patients with hematological malignancies usually receive induction or re induction chemotherapy first. Then, they are assigned either to chemotherapy course or referred to BMT/SCT based on the risk of the disease.

